- Home
- ACXP vs RDI Comparison
ACXP vs RDI Comparison
Compare ACXP & RDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACXP
- RDI
- Stock Information
- Founded
- ACXP 2017
- RDI 1937
- Country
- ACXP United States
- RDI United States
- Employees
- ACXP N/A
- RDI N/A
- Industry
- ACXP Biotechnology: Pharmaceutical Preparations
- RDI Movies/Entertainment
- Sector
- ACXP Health Care
- RDI Consumer Discretionary
- Exchange
- ACXP Nasdaq
- RDI Nasdaq
- Market Cap
- ACXP 31.4M
- RDI 40.4M
- IPO Year
- ACXP 2021
- RDI N/A
- Fundamental
- Price
- ACXP $0.77
- RDI $1.58
- Analyst Decision
- ACXP Strong Buy
- RDI Hold
- Analyst Count
- ACXP 1
- RDI 1
- Target Price
- ACXP $12.00
- RDI $2.40
- AVG Volume (30 Days)
- ACXP 479.2K
- RDI 76.2K
- Earning Date
- ACXP 03-14-2025
- RDI 03-31-2025
- Dividend Yield
- ACXP N/A
- RDI N/A
- EPS Growth
- ACXP N/A
- RDI N/A
- EPS
- ACXP N/A
- RDI N/A
- Revenue
- ACXP N/A
- RDI $197,270,000.00
- Revenue This Year
- ACXP N/A
- RDI N/A
- Revenue Next Year
- ACXP N/A
- RDI $14.40
- P/E Ratio
- ACXP N/A
- RDI N/A
- Revenue Growth
- ACXP N/A
- RDI N/A
- 52 Week Low
- ACXP $0.68
- RDI $1.22
- 52 Week High
- ACXP $3.35
- RDI $2.05
- Technical
- Relative Strength Index (RSI)
- ACXP 42.04
- RDI 53.90
- Support Level
- ACXP $0.70
- RDI $1.53
- Resistance Level
- ACXP $0.87
- RDI $1.87
- Average True Range (ATR)
- ACXP 0.06
- RDI 0.13
- MACD
- ACXP 0.00
- RDI 0.01
- Stochastic Oscillator
- ACXP 22.09
- RDI 40.82
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.
About RDI Reading International Inc
Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial, and live theater assets.